2210404O07Rik Inhibitors encompass a range of compounds that can modulate the activity or function of the protein 2210404O07Rik, also known as SMIM24, through indirect mechanisms. These compounds are chosen based on their known actions on various signaling pathways and cellular processes, representing a broad spectrum of chemical inhibitors that could impact the biological function or expression of SMIM24. For instance, Rapamycin, a well-known inhibitor of the mTOR pathway, could indirectly affect proteins like SMIM24 by altering key cellular processes such as growth and autophagy. This interaction reflects the intricate connection between mTOR signaling and various aspects of cellular function, where modulation of one component can have cascading effects on others, including SMIM24.
Staurosporine, as a kinase inhibitor, may regulate proteins like SMIM24 by inhibiting kinases responsible for their phosphorylation or activation. This could result in alterations in the activity or expression of SMIM24, impacting various cellular functions. Other compounds in this class, such as LY294002, U0126, SB203580, PD98059, and SP600125, target key enzymes within the MAPK signaling pathways, offering additional mechanisms for potentially influencing SMIM24. Their inhibition of enzymes like PI3K, MEK, p38 MAPK, or JNK could indirectly affect SMIM24 if it is part of or regulated by these pathways. Similarly, inhibitors like PP2, targeting Src family kinases, and Bisindolylmaleimide I, inhibiting PKC, may also modulate the function of SMIM24 through related signaling pathways. BAY 11-7082 and LY3214996, targeting NF-kB activation and ERK1/2 respectively, expand the scope of potential indirect modulation of SMIM24. Each compound in this class, with its unique mechanism of action, contributes to the modulation of SMIM24, leveraging the intricacies of cellular signaling and molecular interactions. The diversity of this chemical class reflects the complex nature of cellular regulation and the multiple points of intervention in influencing the activity or expression of SMIM24.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits the mTOR pathway, affecting proteins involved in cell growth and autophagy, including SMIM24. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum kinase inhibitor, inhibiting kinases that phosphorylate or regulate SMIM24. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, affecting downstream signaling pathways that involve SMIM24. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, impacting SMIM24 if regulated by or interacting with this kinase. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK1/2, affecting SMIM24 if involved in the MAPK/ERK signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, affecting SMIM24 if part of the JNK signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, affecting SMIM24 through downstream signaling pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor, indirectly affecting the function of SMIM24. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Inhibits Protein Kinase C (PKC), impacting SMIM24 if associated with the PKC pathway. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-kB activation, impacting SMIM24 if it's involved in the NF-kB signaling pathway. | ||||||